TALAPRO-3 clinical trial protocol: phase III study of talazoparib plus enzalutamide in metastatic castration-sensitive prostate cancer

Future Oncology, Ahead of Print.

Source: Future Oncology - October 26, 2023 Category: Cancer & Oncology Authors: Neeraj Agarwal Fred Saad Arun A Azad Joaquin Mateo Nobuaki Matsubara Neal D Shore Jayeta Chakrabarti Hsiang-Chun Chen Silvana Lanzalone Alexander Niyazov Karim Fizazi Source Type: research